IP Library › Granted Patent US 11,986,828
Granted Patent B2
US 11,986,828 · App. 16/668,169 · Granted May 21, 2024

Pathological slides and related systems and methods

Inventors: Matthew O. Leavitt (Salt Lake City, UT); Mark S. Evans (Orem, UT); Michael Andrew Ivie (Orem, UT)
Assignee: Leavitt Medical, Inc.
B01L3/508G01N1/30G01N1/312G01N35/00029B01L2300/021B01L2300/022B01L2300/0822B01L2300/168
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,986,828
App. No.
16/668,169
Granted
May 21, 2024
Kind
B2
Abstract

The disclosed pathology slides may include a substantially transparent substrate that includes a top major surface, at least two regions on the top major surface of the substantially transparent substrate having a size sufficient for receiving at least two respective biopsy tissue sample sections on the substantially transparent substrate, and at least one visibly perceptible separation mark on or in the substantially transparent substrate separating the at least two regions from each other. Various other related methods and systems are also disclosed.

Claims (16)

1. A pathology slide, comprising:

a substantially transparent substrate that includes a top major surface and a bottom major surface on an opposite side of the substantially transparent substrate from the top major surface;

at least two regions on the top major surface of the substantially transparent substrate, the at least two regions comprising at least two respective portions of the top major surface configured to receive at least two respective biopsy tissue sample sections on the substantially transparent substrate; and

at least one substantially straight separation mark comprising a void in the bottom major surface of the substantially transparent substrate, the at least one separation mark positioned between and separating the at least two regions from each other.

2. The pathology slide of claim 1 , wherein the at least two regions comprise at least three regions configured to receive at least three respective biopsy tissue sample sections, and wherein the at least one separation mark comprises at least two separation marks separating the at least three regions from each other.

3. The pathology slide of claim 1 , further comprising a tracking region adjacent to the at Fast two regions, the tracking region having a size sufficient to receive at least one of:

a radio-frequency identification (RFID) chip;

a slide label; or

a printing medium.

4. The pathology slide of claim 3 , further comprising the slide label adhered to the tracking region.

5. The pathology slide of claim 1 , wherein the substantially transparent substrate comprises a glass substrate.

6. The pathology slide of claim 1 , wherein the at least one separation mark comprises at least one substantially straight line.

7. The pathology slide of claim 1 , wherein the at least one separation mark comprises at least one of: a string of alphanumeric symbols; an orientation arrow; or multiple arrows.

8. The pathology slide of claim 1 , wherein the at least one separation mark comprises: a dashed line; or a dotted line.

9. The pathology slide of claim 1 , wherein the at least one separation mark comprises a first separation mark and a second separation mark.

10. The pathology slide of claim 9 , wherein the first separation mark and the second separation mark have respectively different configurations to distinguish the first separation mark from the second separation mark.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2021
From: LEAVITT, MATTHEW O.; EVANS, MARK S.; IVIE, MICHAEL ANDREW
To: LEAVITT MEDICAL, INC.
Reel/Frame 057522/0620 →
Continuity (2)
Provisional Application 62753917 · Nov 1, 2018
Related Publication 20200139361A1 · May 7, 2020